It’s better days ahead for Canadian cannabis name Indiva Ltd (Indiva Ltd Stock Quote, Charts, News, Analysts, Financials TSXV:NDVA), according to Echelon Capital Markets analyst Andrew Semple who delivered an update to clients on the company on Monday. Semple said Indiva’s growth prospects are good and the company should end 2022 on a profitable note. […]
Pot stock Cronos is a Buy, says Raymond JamesRaymond James analyst Rahul Sarugaser is staying solid in his assessment of Cronos Group (Cronos Group Stock Quote, Chart, News, Analysts, Financials TSX:CRON), maintaining his “Outperform 2” rating and target of $6/share for a projected return of 117.4 per cent in an update to clients on Tuesday. Founded in 2012 and headquartered in Toronto, Cronos […]